Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Mach7 Technologies ( (AU:M7T) ) is now available.
Mach7 Technologies Limited has announced an update regarding its ongoing on-market buy-back program. As of June 30, 2025, the company has repurchased a total of 6,089,862 ordinary fully paid securities, with an additional 170,138 securities bought back on the previous day. This buy-back initiative is part of the company’s strategy to optimize its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:M7T) stock is a Buy with a A$0.95 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.
More about Mach7 Technologies
Mach7 Technologies Limited operates in the technology industry, focusing on providing innovative healthcare solutions. The company specializes in developing software for medical imaging and data management, catering to healthcare providers and institutions.
YTD Price Performance: -13.75%
Average Trading Volume: 271,630
Technical Sentiment Signal: Sell
Current Market Cap: A$83.23M
See more insights into M7T stock on TipRanks’ Stock Analysis page.